Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析

◆英語タイトル:Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12810
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sinphar Pharmaceutical Co Ltd (1734) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sinphar Pharmaceutical Co Ltd (Sinphar) is a healthcare company that carries out the development, manufacture and sale of pharmaceutical drugs, healthy foods and cosmetics. The company’s pharmaceutical product portfolio includes antifungal agents, anti-hypersensitive agents, cardiovascular agents, dermatologic agents, ophthalmic agents, skincare products, health supplements and others. It also has several products in pipeline addressing dementia, dry age-related macular degeneration, triple-negative breast cancer, pancreatic cancer, genital warts and others. Sinphar also offers contract manufacturing services to pharmaceutical companies for the development of new products. It has presence in China, Taiwan, Canada and other countries. Sinphar is headquartered in Tungshan, Yilan, Taiwan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Sinphar Pharmaceutical Co Ltd – Key Facts 5
Sinphar Pharmaceutical Co Ltd – Key Employees 6
Sinphar Pharmaceutical Co Ltd – Key Employee Biographies 7
Sinphar Pharmaceutical Co Ltd – Major Products and Services 8
Sinphar Pharmaceutical Co Ltd – History 9
Sinphar Pharmaceutical Co Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Sinphar Pharmaceutical Co Ltd – Business Description 12
Sinphar Pharmaceutical Co Ltd – SWOT Analysis 13
SWOT Analysis – Overview 13
Sinphar Pharmaceutical Co Ltd – Strengths 13
Sinphar Pharmaceutical Co Ltd – Weaknesses 14
Sinphar Pharmaceutical Co Ltd – Opportunities 15
Sinphar Pharmaceutical Co Ltd – Threats 16
Sinphar Pharmaceutical Co Ltd – Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios – Capital Market Ratios 18
Financial Ratios – Annual Ratios 19
Performance Chart 22
Financial Performance 22
Financial Ratios – Interim Ratios 23
Financial Ratios – Ratio Charts 24
Section 4 – Company’s Lifesciences Financial Deals and Alliances 25
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26
Sinphar Pharmaceutical Co Ltd, Recent Deals Summary 27
Section 5 – Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Sinphar Pharmaceutical Co Ltd, Key Facts 5
Sinphar Pharmaceutical Co Ltd, Key Employees 6
Sinphar Pharmaceutical Co Ltd, Key Employee Biographies 7
Sinphar Pharmaceutical Co Ltd, Major Products and Services 8
Sinphar Pharmaceutical Co Ltd, History 9
Sinphar Pharmaceutical Co Ltd, Subsidiaries 10
Sinphar Pharmaceutical Co Ltd, Key Competitors 17
Sinphar Pharmaceutical Co Ltd, Ratios based on current share price 18
Sinphar Pharmaceutical Co Ltd, Annual Ratios 19
Sinphar Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 20
Sinphar Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 21
Sinphar Pharmaceutical Co Ltd, Interim Ratios 23
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26
Sinphar Pharmaceutical Co Ltd, Recent Deals Summary 27
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

List of Figures
Sinphar Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 22
Sinphar Pharmaceutical Co Ltd, Ratio Charts 24
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25
Sinphar Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 26

★海外企業調査レポート[Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Perpetual Energy Systems, LLC:企業のM&A・提携動向(発電分野)
    Summary Perpetual Energy Systems, LLC (Perpetual Energy) a subsidiary of The Alliant Company, LLC is an alternative energy company that offers financial services. The company provides solar energy systems and related financial and investment services. It offers access to renewable solar energy syste …
  • Stagecoach Group plc:企業の戦略・SWOT・財務分析
    Stagecoach Group plc - Strategy, SWOT and Corporate Finance Report Summary Stagecoach Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bechtle AG (BC8):企業概要、財務及び戦略的SWOT分析
    Summary Bechtle AG (Bechtle) is an IT e-commerce solution provider. The company operates under two business segments; IT e-commerce and IT system house and managed services. Its IT system house and managed services segment offers enterprises supply of hardware and software, project planning and impl …
  • Standard Life plc (SL.):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Standard Life plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows …
  • MediaTek, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MediaTek, Inc. Mergers and Acqu …
  • Oncolys BioPharma Inc (4588)-医療機器分野:企業M&A・提携分析
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OB …
  • Ultra Electronics Holdings plc(航空宇宙・防衛):企業概要及びSWOT/財務分析
    Summary "Ultra Electronics Holdings plc : Aerospace and Defense - Company Profile, SWOT and Financial Analysis" report, published by Strategic Defence Intelligence provides a succinct overview of the company and its operations, detailing their current and future position within the aerospace and def …
  • Olam International Ltd:戦略・SWOT・企業財務分析
    Olam International Ltd - Strategy, SWOT and Corporate Finance Report Summary Olam International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • San Leon Energy Plc (SLE):企業概要、財務及び戦略的SWOT分析
    Summary San Leon Energy Plc (San Leon) is an energy company. The company carries out exploration and production of oil and gas assets. It has assets in Albania, Germany, Ireland, Italy, Morocco, Poland, Spain and France. San Leon holds a 100% interest in the Durresi Block, offshore Albania and its l …
  • DiaGenic ASA (NEL):(医療機器分野)企業M&A及び提携動向
    Summary DiaGenic ASA (DiaGenic) is a diagnostic company. The company undertakes the development of novel and patient-friendly in vitro diagnostics for early detection of diseases. It specializes in developing blood-based biomarkers for early detection of Alzheimer’s disease. The company’s ADtect pro …
  • Sunoco LP (SUN):企業概要、財務及び戦略的SWOT分析
    Summary Sunoco LP (Sunoco), formerly Susser Petroleum Partners LP, is a wholesale distributor of motor fuels and other petroleum products. It is one of the largest non-refining fuel distributors in Texas. The company carries out the lease or sublease of the petroleum products and lubricants to indep …
  • Prysmian S.p.A (PRY):企業のM&A・提携動向(エネルギー分野)
    Summary Prysmian S.p.A (Prysmian) is a supplier of high-technology cables and systems. It develops, designs, produces, supplies and installs a wide portfolio of cables for various applications in Energy and Telecom industries. The company provides underground and submarine power transmission cables …
  • JD.com Inc:企業の戦略・SWOT・財務情報
    JD.com Inc - Strategy, SWOT and Corporate Finance Report Summary JD.com Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Conversant, Inc. (formerly ValueClick, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Conversant, Inc. (formerly Valu …
  • Sundance Energy Australia Limited (SEA):企業のM&A・提携動向(石油・ガス分野)
    Summary Sundance Energy Australia Limited (Sundance Energy) is an oil and gas company that acquires, explores and develops oil and natural gas. The company develops various projects in the Denver-Julesburg Basin located in the northern Colorado and southern Wyoming. It also conducts drilling program …
  • Raffles Education Corporation Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Raffles Education Corporation L …
  • Polycom Inc:企業の戦略的SWOT分析
    Polycom Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • AsianLife & General Assurance Corporation:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "AsianLife & General Assurance Corporation" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. T …
  • Paikkwang Industrial Co., Ltd (001340):企業概要、財務及び戦略的SWOT分析
    Summary Paikkwang Industrial Co., Ltd. (Paik Kwang) is a chemical company. The company manufactures, develops, supplies and sells L-lysine, chlor-alkali, sugar alcohol products. Its chlor-alkali products include synthetic hydrochloric acid, sodium hypochlorite and compressed hydrogen. Paik Kwang’s s …
  • Rexam PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rexam PLC Mergers and Acquisiti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆